https://www.zacks.com/stock/news/2228928/teladoc-tdoc-q4-earnings-how-key-metrics-compare-to-wall-street-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2228928
Feb 20, 2024 - The headline numbers for Teladoc (TDOC) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
zc:-6299758230078128646
0
https://www.zacks.com/stock/news/2228925/compared-to-estimates-community-health-systems-cyh-q4-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2228925
Feb 20, 2024 - Although the revenue and EPS for Community Health Systems (CYH) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
zc:-7137161633740017661
0
https://www.zacks.com/stock/news/2228926/national-health-investors-nhi-q4-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2228926
Feb 20, 2024 - While the top- and bottom-line numbers for National Health Investors (NHI) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
zc:-5414805722004502380
0
https://www.zacks.com/stock/news/2228934/toll-brothers-tol-q1-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2228934
Feb 20, 2024 - Although the revenue and EPS for Toll Brothers (TOL) give a sense of how its business performed in the quarter ended January 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
zc:-3642210027469533444
0
https://www.zacks.com/stock/news/2228933/compared-to-estimates-globus-medical-gmed-q4-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2228933
Feb 20, 2024 - The headline numbers for Globus Medical (GMED) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
zc:7983296323133003493
0
https://www.zacks.com/stock/news/2228930/solaredge-sedg-q4-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2228930
Feb 20, 2024 - While the top- and bottom-line numbers for SolarEdge (SEDG) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
zc:-5515231940818112029
0
https://www.zacks.com/stock/news/2228932/here-s-what-key-metrics-tell-us-about-ringcentral-rng-q4-earnings?cid=CS-ZC-FT-fundamental_analysis|nfm-2228932
Feb 20, 2024 - While the top- and bottom-line numbers for RingCentral (RNG) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
zc:7491045600502661148
0
https://www.zacks.com/stock/news/2228931/neogenomics-neo-q4-earnings-how-key-metrics-compare-to-wall-street-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2228931
Feb 20, 2024 - While the top- and bottom-line numbers for NeoGenomics (NEO) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
zc:6859535301960195664
0
https://www.zacks.com/stock/news/2228929/abcellera-biologics-inc-abcl-q4-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2228929
Feb 20, 2024 - Although the revenue and EPS for AbCellera Biologics Inc. (ABCL) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
zc:9050836874667715030
0
https://www.zacks.com/stock/news/2228935/select-water-solutions-inc-wttr-reports-q4-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2228935
Feb 20, 2024 - Although the revenue and EPS for Select Water Solutions, Inc. (WTTR) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
zc:5213971328899505564
0